Unmet Diagnostic Needs in Infectious Disease
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Unmet Diagnostic Needs in Infectious Disease
  • Published Date:

    Oct 25 2014

  • Publisher's site:
    http://dx.doi.org/
  • Source:
    Diagn Microbiol Infect Dis. 2014; 81(1):57-59.
Filetype[PDF-280.31 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 507.55 KB]
    Personal Author:
    Hughes, J. M.
    Published Date:
    2001
    Source:
    Emerg Infect Dis. 7(3 Suppl):494-496.
    File Type:
    Filetype[PDF - 507.55 KB]
  2. Filetype[PDF - 45.38 KB]
    Personal Author:
    Tamma, Pranita D.; Srinivasan, Arjun; Cosgrove, Sara E.;
    Published Date:
    Jun 2014
    Source:
    Infect Dis Clin North Am. 28(2):xi-xii
    File Type:
    Filetype[PDF - 45.38 KB]
  3. Filetype[PDF - 2.20 MB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. Laboratory Branch.
    Published Date:
    June 2012
    Description:
    ..The ability to rapidly and accurately detect drug resistance in Mycobacterium tuberculosis complex (MTBC) is critical for the effective treatment of patients suffering from tuberculosis (TB) and relevant interventions of TB control programs. Effort...
    File Type:
    Filetype[PDF - 2.20 MB]
  4. Filetype[PDF - 349.70 KB]
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector Borne Diseases. Bacterial Diseases Branch.
    Published Date:
    10/25/11
    Description:
    The likelihood that a patient has a disease depends on many factors:• Has the patient been in an area where the disease is found?• Does the patient have signs and symptoms typical ofthe disease?• Does the patient have risk factors for contracti...
    File Type:
    Filetype[PDF - 349.70 KB]
  5. Filetype[PDF - 358.78 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/14/19
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2018
    AR solutions in action
    Description:
    $653,896 Funding for AR Activities Fiscal Year 2018See CDC’s AR investments by state at www.cdc.gov/ARinvestments.Publication date from document properties.Houston-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 358.78 KB]